TORONTO, March 18, 2022 /CNW/ - Franco-Nevada Corporation announced that its Annual Information Form, Consolidated Annual Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2021 have been filed with Canadian securities regulatory authorities. Franco-Nevada has also filed its Form 40-F for the year ended December 31, 2021 with the U.S. Securities and Exchange Commission. Copies of these documents may be obtained via www.sedar.com or www.sec.gov (for the Form 40-F).
Shareholders may also receive a copy of these documents without charge upon request to Franco-Nevada's Investor Relations Department, 199 Bay Street, Suite 2000, P.O. Box 285, Commerce Court Postal Station, Toronto, Ontario, Canada M5L 1G9 or to email@example.com.
Details for Virtual Investor Day
Franco-Nevada's management team will host a Virtual Investor Day webcast, April 14, 2022 from 10:00 am ET to 12:00 pm ET to review its assets and to announce the release of the 2022 Asset Handbook and 2022 Environment, Social and Governance Report (ESG Report). Interested investors and analysts are invited to participate as follows:
Virtual Investor Day Webcast:
April 14th at 10:00 am ET to 12:00 pm ET
North American Toll Free: 1–888–390–0546
Local and International: 416–764–8688
Replay (available until April 21st):
North American Toll Free: 1–888–390–0541
Local and International: 416–764–8677
Pass code: 836179 #
Franco-Nevada Corporation is the leading gold-focused royalty and streaming company with the largest and most diversified portfolio of cash-flow producing assets. Its business model provides investors with gold price and exploration optionality while limiting exposure to cost inflation. Franco-Nevada is debt-free and uses its free cash flow to expand its portfolio and pay dividends. It trades under the symbol FNV on both the Toronto and New York stock exchanges. Franco-Nevada is the gold investment that works.
SOURCE Franco-Nevada Corporation
View original content: http://www.newswire.ca/en/releases/archive/March2022/18/c0297.html